Delivery Order SPE2DB22D2007-SPE2DB25FJ3TQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,857.40 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/mL syringes on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Prolia is a prescription medication used primarily for treating osteoporosis and bone loss in...
- The Defense Logistics Agency awarded a $26,999.75 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Prolia 60 mg/ml syringes. This firm fixed price contract is non-competitive with no set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,214.35 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringe on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $32,625.43 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 20, 2025. This is a firm fixed-price, non-set-aside contract executed on August 19, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $16,071.75 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROLIA 60 MG/ML SYRINGEML. The contract has a potential value of $4,701.42 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,743.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Prolia 60 mg/mL syringes. The contract has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- This delivery order for $17,990.80, awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corporation, is for 4562538166 units of Prolia 60 mg/ml syringes with a completion date of October 20, 2023. The firm fixed price contract was awarded on October 19, 2023 without a set-aside designation. Prolia is a treatment for osteoporosis administered via injection. This order will supply the Defense Logistics Agency's medical programs with the specified...
- The Defense Logistics Agency awarded a $12,726.40 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, with an ultimate completion date of July 28, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PROLIA 60 MG/ML SYRINGEML. The contract has a ceiling value of $2,615.13 and a performance period through March 21, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor and the parent company is Cencora, Inc. doing business as...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3TQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,912.73 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 8, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on August 7, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. Prolia is a prescription medication used to treat osteoporosis and increase bone mass in patients at risk for fractures. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime pharmaceutical supply contract serves as a comprehensive global vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's extensive federal contract portfolio with DLA demonstrates its established capability to fulfill federal medical procurement requirements, serving defense and veteran healthcare systems with brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.9k | 8/7/25 |